Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-04-18
1987-08-04
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3702
Patent
active
046846220
ABSTRACT:
Vasopressin derivatives having V.sub.1 and oxytocin antagonist activity whose structures are characterized by a Mpa unit at position 1 and a des-Pro unit at position 7 are prepared by standard peptide synthetic methods also using an oxidative cyclization of a dimercaptan. Representative species are [1-deaminopenicillamine-2-(O-methyl)-tyrosine-7-desproline-8-arginine-9-de sglycine]vasopressin or [1-.beta.-mercaptopropionic acid-2-D-(O-ethyl)tyrosine-3-isoleucine-4-threonine-7-desproline-8-arginin e-9-desglycine]-vasopressin.
REFERENCES:
patent: 3941763 (1976-03-01), Sarantakis
patent: 4599324 (1986-07-01), Ali et al.
Rudinger, Peptide Hormones, Parsons (ed.), U. Park Press, Baltimore, 1976, pp. 1-7.
Ali Fadia E.
Huffman William F.
Brown Johnnie R.
Daniel Mark R.
Lourie Alan D.
Moezie F. T.
SmithKline Beckman Corporation
LandOfFree
Compositions and methods for producing vasodilation and antioxyt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for producing vasodilation and antioxyt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for producing vasodilation and antioxyt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-883851